california senate passes biosimilar substitution bill with a 31 to 4 vote and now awaits committee...

7
California Senate Passes Biosimilar Substitution Bill with a 31 to 4 vote and Now Awaits Committee Assignment in the Assembly. Powered by Small World Social www.biolink.us

Upload: small-world-social

Post on 06-Aug-2015

146 views

Category:

Healthcare


0 download

TRANSCRIPT

California Senate Passes Biosimilar Substitution Bill with a 31 to 4 vote and Now Awaits Committee Assignment in the Assembly.

Powered by Small World Social

www.biolink.us

Powered by Small World Social

California is the latest U.S.

state to pass biosimilar

substitution legislation.

California’s Senate has passed the

biosimilar substitution bill, SB 671 (Hill),

by a vote of 31 to 4 on May 22.

Previously vetoed in 2013, the bill is

currently awaiting committee assignment

in the Assembly. The bill authorizes a

pharmacist to substitute an alternative

biological product when filling a

prescription for a prescribed biological

product under specified circumstances.Biolink.us

Powered by Small World Social

Provisions of the legislation include:

• Only FDA-designated interchangeable

biologics may be substituted.

• Prescribers may prevent substitution

by writing “do not substitute” on the

prescription.

• A pharmacist must communicate a

substitution to the prescriber and

patient within five days of dispensing

the product.

Biolink.us

Powered by Small World Social

In a press release praising this latest

legislative development for

biosimilars, the California

Rheumatology Alliance said: “This

important milestone means that the

discussions around biosimilar bills in

state legislatures are no longer

conceptual.”

Biolink.us

Powered by Small World Social

According to the National

Conference of State

Legislatures website,

biosimilars substitution

legislation has already been

passed into law in Delaware,

Florida, Indiana,

Massachusetts, North Dakota,

Oregon, Utah and Virginia.

These laws apply to the

substitution of biosimilars at

the retail pharmacy level, but

not to mailorder

pharmaceutical sales.Biolink.us

Powered by Small World Social

Meanwhile, California joins other U.S.

states including New Jersey,

Pennsylvania, Texas and Illinois with

legislation pending passage into enacted

law.

Read More on BioLink:

https://biolink.smallworldsocial.com/porta

l#/?id=

5575c2309ccf1d0d24cfc831

Biolink.us

Visit https://biolink.us to get the latest in biosimilar news curated from around the world

Powered by Small World Social

www.biolink.us

Want to read more about biosimilars?